Seven abstracts have been selected for the Late Breaking Science session at the American Academy of Neurology Annual Meeting in Honolulu, March 29-April 5, 2003. The Late Breaking Science Program highlights the most current research.
Abstracts qualify for Late Breaking Science presentations by having key aspects of research conducted after the November 14, 2002 deadline for abstract submissions. The abstracts must be new and of sufficient scientific importance to warrant expedited presentation and publication.
The following abstracts will be presented during the Late Breaking Science Platform Session on Tuesday, April 1 starting at 3:45 p.m.:* Vitamin Intervention for Stroke Prevention Results and Conclusion; James F. Toole, MD, Winston-Salem, NC* EN101: A Novel Antisense Therapeutic Strategy for Myasthenia Gravis; Zohar Argov, MD, Jerusalem, Israel* Accumulation of Mutant UBB (UBB+1) in Muscle Fibers Implicates a Novel Mechanism of Molecular Misreading in the Pathogenesis of Inclusion-Body Myositis; Pietro Fratta, MD, Los Angeles, CA* 'Late Onset' Presentation of Congenital Myasthenia Due To Mutations in Rapsyn; Georgina Burke, MD, Oxford, United Kingdom* A Single One-Hour Application of High-Concentration Capsaicin Patches Leads to Four Weeks of Pain Relief in Postherpetic Neuralgia Patients; Misha-Miroslav Backonja, MD, Madison, WI
The following abstracts will be presented during Poster Session 2 on Tuesday, April 1 at 5:30 p.m.:* Mutations in MTMR13, a New Pseudo-Phosphatase Homologue of MTMR2 and Sbfl, Causes ARCMT Associated with Glaucoma; H. Azzedine, PhD, Paris, France* HLA Class II Transgenic Mice as Humanized Models of Multiple Sclerosis; Chella S. David, PhD, Rochester, MN
The American Academy of Neurology, an association of more than 18,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research.
RSS